Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
| Pfizer's Sutent Disappoints Again - Zacks.com |
|
|
|
Zacks.comThe product is currently in phase III studies for advanced castration-resistant prostate cancer and for renal cell carcinoma (as adjuvant therapy). ...Pfizer's Bad Luck with Expanding Sutent's Use Continues Genetic Engineering NewsPfizer's Sutent Misses The Mark ForbesTopline Results From Phase 3 Trial of Sunitinib With Erlotinib in Advanced Non ... read more |
Professional dialysis recruitment

